Burzynski Research Institute

This study tests whether adding Antineoplaston therapy (Atengenal and Astugenal) to standard radiation helps people aged 3 and older with a newly diagnosed, aggressive brainstem glioma live longer. About 92 participants will be randomly assigned to get either the drug combo plus …

This study checks if an experimental treatment called antineoplaston therapy changes heart rhythm in children and young adults (ages 3-21) with a rare, aggressive brainstem glioma. Participants will receive either antineoplaston therapy plus radiation or radiation alone. The main…